Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
The Data Safety Monitoring Board has recommended that the trial known as DESTINY PWS continue without changes
Aequus is set to receive commercial rights to Medicom’s Evolve line of preservative-free dry eye products within Canada
Pulmonary hypertension occurs in 6% to 74% of patients with sarcoidosis ...
The Houston, Texas-based immuno-oncology group gave an update on five clinical trials
The latter offers same-day, 60-minute delivery services in multiple industries across Canada
Tong is currently the finance chief at ExGen Resources and is a senior advisor to several companies
The firm is behind the VMS Plus, an accurate AI (artificial intelligence) tool for measuring whole heart function
The proceeds will be used for sales and marketing, development and general working capital
Analyst Craig Stanley, back from a site visit, repeated a 'buy' on the stock
The Tiple Block acreage is adjacent to Geopark’s prolific Llanos 34 Block
A look at some of the analyst comment on North America listed stocks on Monday
A look at some analyst views from around the City on Friday